Regulatory & Legal

Positive Phase 3 results for BBP-418 offer a potential first-ever treatment for LGMD2I/R9, a progressive muscle disease with no current therapies.

Industry pioneer Lee Leichter joins EdgeOne Medical, a strategic move to master the complex, high-stakes world of combination product regulation.

Selected for a key federal initiative, Elroy Air's Chaparral drone will pioneer autonomous cargo delivery in the Gulf Coast, accelerating a new era of logistics.

Beyond the charging pad, a startup's successful $1.2M raise signals a new era of 'power like Wi-Fi' for all our devices, from desk to room scale.

As AI progress stalls on bad data, a new research lab is bringing scientific discipline to the industry's most overlooked and critical pillar.

Belize launches a landmark partnership to combat preventable blindness, aiming to provide affordable eye care to all. But can it overcome systemic challenges?

Ag-tech giant Syngenta partners with KOMO Biosciences to evaluate a novel gene-insertion platform, aiming to create climate-resilient maize for the future.

Alectra Utilities is investing $46 million to upgrade Mississauga's aging power grid, aiming to support massive urban growth and prevent outages.

Accel Solutions Group and Palo Alto Networks secure Israel's largest network security tender, a deal worth up to NIS 500M to protect critical infrastructure.

New AI-powered screening solution aims to slash false positives and help smaller financial institutions combat complex financial crime and reputational risk.

AVANCE Global and We Are All Human merge their influential platforms, creating a new epicenter for celebrating Hispanic economic and cultural achievement.

A shocking $178M charge-off sends goeasy Ltd. shares plummeting, erasing billions in value and triggering a probe by a leading securities law firm.

The deal with Ahngook Pharm for its GMRx2 single-pill therapy marks a key step in a global strategy validated by recent US FDA approval.

Amid rising costs and AI anxiety, a new poll shows consumers trust value and consistency, boosting Costco to #1 while Target and tech giants falter.

The tech firm is launching a new transparent, scenario-based AI to de-risk the multi-billion dollar drug development pipeline. But can it succeed?

After a year-long activist campaign and a proxy battle, UniFirst yields to pressure, agreeing to a landmark sale to rival Cintas for $5.5 billion.

A new report says 10 advanced reactors could add $1T to the U.S. economy, but past project failures and major workforce hurdles cast a long shadow.

A new report reveals that while AI accelerates coding, it's causing more deployment failures, security risks, and pushing engineering teams to their limits.

EarnIn’s Live Pay surpasses one million transactions, but a complex web of fees, competition, and regulatory scrutiny challenges the future of instant income.

A landmark study reveals a new test can predict and help prevent premature births in low-risk pregnancies, with a Texas hospital playing a leading role.